|
Synonyms: Natpar® | Natpara® | rhPTH[1-84]
PTH is an approved drug (FDA (2015), EMA (2017))
Compound class:
Endogenous peptide in human, mouse or rat
Comment: In its recombinant form, human parathyroid hormone was approved for clinical use in 2015, under the name Natpara.
Species: Human
View more information in the IUPHAR Pharmacology Education Project: pth |
| No information available. |
Summary of Clinical Use  |
| Approved for use in patients with hypoparathyroidism to control low blood calcium levels. |
| Mechanism Of Action and Pharmacodynamic Effects |
| PTH increases levels of calcium in the blood through its interaction with the PTH1 receptor. |
| External links |
|
For extended ADME data see the following: Drugs.com European Medicines Agency (EMA) |
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
